{
  "main_header": {
    "sid": 10039887,
    "name": "Corona Remedies",
    "stock_name": "Corona Remedies",
    "full_name": "Corona Remedies Ltd",
    "name_url": "stocks-analysis/corona-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,501.10",
    "chg": 43.9,
    "chgp": "3.01%",
    "dir": 1,
    "prev_price": "1,457.20",
    "mcapval": "8,786.00 Cr",
    "mcap": "",
    "scripcode": 544644,
    "symbol": "CORONA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE02ZQ01018",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "75.02 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039887",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/corona-remedies-10039887"
  },
  "announcements": [
    {
      "caption": "Financial Results For The Third Quarter And Nine Months Ended December 31 2025",
      "datetime": "02-Feb-2026",
      "details": "Financial Results for the Third Quarter and Nine Months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "02-Feb-2026",
      "details": "Outcome of Board Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "02-Feb-2026",
      "details": "Analyst/Investor Presentation",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News